In people diagnosed with lymphoma receiving immunochemotherapy treatment, a combined exercise intervention, as opposed to the general recommendations, will achieve: 1.Improve cardiorespiratory fitness, strength, psychological well-being and quality of life. //2.Reduce fatigue//3.Reduce frailty
There is an association between some biological biomarkers with physical capacity and frailty.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Age: ≥18 years old.
* Diagnosis of lymphoma with histological confirmation and requirement of systemic treatment including chemotherapy.
* Time available (80 minutes, two days a week for 20 weeks) to carry out physical exercise sessions.
* Have a mobile phone to be able to con…
Inclusion Criteria:
* Age: ≥18 years old.
* Diagnosis of lymphoma with histological confirmation and requirement of systemic treatment including chemotherapy.
* Time available (80 minutes, two days a week for 20 weeks) to carry out physical exercise sessions.
* Have a mobile phone to be able to contact the person and download the physical activity level app.
* Eastern Cooperative Oncology Group performance status (ECOG) ≤2.
* Life expectancy \>12 months.
* Availability and desire to participate throughout the study period.
Exclusion Criteria:
* Have a contraindication to moderate-high intensity exercise.
* Other significant medical disorders: including psychiatric illnesses chronic or recurrent; intellectual disability, musculoskeletal problems, cardiac or pulmonary disorders that interfere with physical exercise; other malignant tumors in the last five years, with the exception of therapeutically controlled skin cancer; any other illness that may be seen affected or aggravated by physical exercise.
* Have plans to be outside city more than two weeks.
* People who are already physically active (that comply with the recommendations of WHO: \> 150 minutes of exercise moderate/weekly, plus training force two days/week).
* Treatment based only with immunotherapy.
* Central nervous system involvement due to lymphoma.
* Have any important history that limit the capacity of the patient to participate in the study.
Contacts
Clinical Research Platform - Health Research Institut Biogipuzkoa
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
